News – Page 1123 – Endpoints News

Playing catch-up, Eli Lilly is hustling positive PhIII CGRP migraine data to the FDA as late-stage rivalry heats up

9 years ago

Ardelyx rolls out positive PhIII IBS-C data on tenapanor as rivals prep for a showdown, but shares crater

9 years ago

AstraZeneca’s shares spike on a surprise coup in PhIII lung cancer data

9 years ago

Scott Gottlieb is sworn in as FDA commissioner

9 years ago

Regulators order AB Science to halt trial work on PhIII ALS drug, demanding proof it's cleaned up

9 years ago

Astellas dumps a PhIII lung cancer drug; GSK gets one success, one failure in a pair of pivotal Crohn’s trials

9 years ago

Shares soar as ‘breakthrough’ news in biotech continues to run hot this week

9 years ago

It’s all quite satisfactory, merci: Sanofi chairman Serge Weinberg shrugs off growing calls for an M&A deal

9 years ago

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

9 years ago

Array shares surge as second chapter of its PhIII cancer combo story ends on an upbeat note

9 years ago

Merck increases grip on its lead in lung cancer, winning approval for Keytruda/chemo combo as first-line therapy

9 years ago

Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal

9 years ago

From Biogen’s buy side to biotech CEO: Josh Mandel-Brehm joins the Polaris family as a serial entrepreneur in the ...

9 years ago

As M&A buzz heats up, Parexel plans 1,200 layoffs; Grünenthal is hiring for its new Boston/Cambridge center

9 years ago

New study points to a double-digit hike in branded drug prices, spotlighting a growing national debate

9 years ago

AstraZeneca’s PhIII bid on asthma drug tralokinumab flops, and that’s no surprise

9 years ago

In a stunning setback, Roche says its top cancer drug Tecentriq failed a key PhIII study

9 years ago

Scoop: Turing is considering a $100M cash offer for the drug that triggered a national scandal over drug pricing

9 years ago

It’s official: Senate confirms Scott Gottlieb as the country’s next FDA commissioner

9 years ago

PhRMA drums out 22 members who didn’t make the cut as major league R&D players

9 years ago

Synergy Pharma preps step 2 for Trulance as positive PhIII IBS-C data squares off against Ironwood and Ardelyx

9 years ago

Scott Gottlieb clears another hurdle in last stretch ahead of the FDA; Sanofi inks €250M bispecific discovery deal ...

9 years ago

Recro Pharma tees up an NDA for its COX-2 pain drug following positive PhIII program

9 years ago

After Kite Pharma stuns analysts with news of a death in lead CAR-T study, safety questions sour launch forecast

9 years ago

First page Previous page 1120 1121 112211231124 1125 1126 Next page Last page